Literature DB >> 16415482

Large and micro coronary vascular involvement in diabetes.

Antonio L'Abbate1.   

Abstract

Diabetes, with hyperglycemia as its hallmark, is a major risk factor for ischemic heart disease. The role of coronary disease in the adverse prognosis of diabetes is controversial although the higher prevalence and extension of coronary atherosclerosis is well recognized. The paper reviews the available evidence of coronary involvement in diabetes with particular emphases on microcirculation. Several studies, mainly in type 2 diabetes, have documented a reduced coronary flow reserve even in absence of coronary obstructive disease and using different techniques. Microcirculatory dysfunction affects the left ventricle globally as well as regionally. However, neither the prevalence of such abnormality in the diabetic population nor its time course and its prognostic value have been investigated in specifically addressed studies. In fact, a relatively large number of studies on myocardial perfusion performed by single-photon myocardial scintigraphy in asymptomatic diabetics rather address the problem of the prevalence of silent ischemia and its prognostic value. In spite of such limitation it can be speculated from the few available studies with known coronary anatomy that the prevalence of exclusively regional disturbances of perfusion (scintigraphic defects) in absence of obstructive coronary disease is not marginal as it ranges from 11 to 63%. Extensive research is still required to define the pathogenesis and the actual clinical relevance of coronary microcirculatory dysfunction in diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 16415482

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  3 in total

Review 1.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

Review 2.  Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart.

Authors:  Alicia D'Souza; Munir Hussain; Frank C Howarth; Niall M Woods; Keshore Bidasee; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2009-05-23       Impact factor: 3.396

Review 3.  Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action.

Authors:  Yoshihito Fujita; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2014-04-02       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.